Skip to content

 News and Events  

Official Danish Life Sciences Forum News and Events page.

Danish Life Sciences News and Events

                                                      News and Events

Growing the Life Sciences Industry: Improving Access, Affordability & Appropriate Use of Medicines

On September 25, 2018, a moderated discussion took place in Ottawa to look at examples from Canada and Denmark on approaches for improving affordability of and access to innovative medicines, while at the same time growing the knowledge-based economy. The event was moderated by Ilse Treurnicht, Former CEO, MaRS Discovery District and opening remarks were delivered by the Danish Ambassador to Canada, Thomas Winkler. Panellists included Hans Erik Henriksen, CEO Healthcare Denmark, Brian Hilberdink, President, Novo Nordisk Canada Inc., and Sheryl Groeneweg, Director General, Manufacturing & Life Sciences Branch Innovation, Sciences and Economic Development Canada.


Click here to watch the full event and discussion.


Denmark Launches a Life Sciences Growth Plan

Denmark has launched a new Life Sciences Growth Plan, which aims to strengthen one of Denmark's leading industries. The plan includes 36 initiatives, targeting barriers and opportunities for the industry across the entire value chain. Although Danish life sciences companies are already leading in global markets, there is general recognition that in order to remain competitive, it requires a constant focus on strengthening innovation, research and product development.

                                                     Formal Submissions

Ontario`s 2019 Budget Inputs

Please read our Ontario's 2019 budget inputs here.

Pre-Budget Submission

In response to the Pre-Budget Consultations in advance of the 2019 budget launched by the Standing Committee on Finance, the Danish Life Sciences Forum submitted recommendations to support the topic of Economic Growth: Ensuring Canada's Competitiveness. The Danish Life Sciences Forum has offered its perspectives on how the federal government can use innovation in the life sciences industry as a way to diversify the economy, increase productivity and competitiveness, and attract and retain the jobs of tomorrow.

Please review the full pre-budget submission here.

Treasury Board Secretariat’s regulatory modernization initiative submission – September 14, 2018

The Danish Life Sciences Forum provided input on the Treasury Board Secretariat’s regulatory modernization initiative. The submission is complementary to that of the industry association, Innovative Medicines Canada (IMC), and focuses on one of the three key sectors that have been targeted for the three-year regulatory review process: health and bio-sciences. The submission focuses on Health Canada’s proposed reform of the PMPRB, which runs contrary to the Treasury Board Secretariat’s efforts to streamline regulation in health and bio-sciences.


Please review the full submission here.

Danish Life Sciences Forum provides input to the Advisory Council on the Implementation of National Pharmacare

On Friday, September 28, Danish Life Sciences Forum provided input on the Advisory Council's implementation of National Pharmacare. The input submission is complementary to that of the industry association, Innovative Medicines Canada (IMC), and provides a Danish perspective on the national pharmacare discussions, conveying six specific recommendations for the Advisory Council's further development of a national pharmacare system in Canada.

Please find the full input submission here.  


Contact us:

Trade Council of Denmark

2 Bloor Street West

Suite 2120

Toronto, Ontario

M4W 3E2

Tel. (416) 962-5661

Fax: (416) 962-3668


Contact Health and life sciences sector

Kerry Allerton

Senior Trade Advisor
Healthcare and Life Sciences
001 (416) 640 1301


Robby  Spring

Trade Advisor
Healthcare and Life Sciences

001 (416) 640 1301